At present, in the healthcare field, increase in antibiotic resistance and dearth of new antibiotics is a major concern of health caregivers worldwide. To combat this, limiting the use of antibiotics is seemingly the only solution to preserve their effectiveness and reduce resistance against them.
Meanwhile, for antibiotics, relatively long courses of treatment is a standard. This, however, is based on medical tradition rather than based on sound scientific evidence. For example, for bacteraemia – a common but potentially threatening bloodstream infection – a common practice is to prescribe a 14-day course of antibacterial treatment.
Study demonstrates Shorter Antibiotic Course equally Effective
Alternately, a team of physicians from the University Hospitals of Geneva, the Centre Hospitalier Universitaire Vaudois, the Cantonal Hospital St. Gallen, and the University of Geneva, in Switzerland, in a multicenter study, vied to test, if a shorter treatment to not account for resistance was possible. Resultantly, the treatment duration reduced by half served to be equally effective.
Besides this, scientists demonstrated tailoring of antibiotic regimen to serve each patient’s individual characteristics and disease patterns allows to reduce the drug dose without loss of therapeutic benefit. Therefore, this work leads to new recommendations that aim to promote the rational use of antibiotics, and this remains the best weapon against bacteria responsible for many diseases.
Bacteraemia refers to a blood infection that is usually related with urinary or pulmonary infections that is caused by a number of types of bacteria. The disease is very common among the elderly, and because it is severe, it requires effective treatment by antibiotics. As a common practice, most physicians as a routine prescribe a 14-day antibiotic course, even if the patient shows rapid improvement in condition.